Lazard Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,090
Closed -$16.2K 2001
2025
Q4
$16.2K Buy
+14,090
New +$19.4K ﹤0.01% 1835
2020
Q4
Sell
-1,753,445
Closed -$2.52M 1920
2020
Q3
$2.52M Buy
1,753,445
+997,103
+132% +$1.78M ﹤0.01% 694
2020
Q2
$1.51M Buy
+756,342
New +$1.48M ﹤0.01% 715
2020
Q1
Sell
-5,600
Closed -$23K 1665
2019
Q4
$23K Buy
+5,600
New +$21.6K ﹤0.01% 1201
2019
Q1
Sell
-45,200
Closed -$300K 1181
2018
Q4
$300K Buy
+45,200
New +$366K ﹤0.01% 833
2016
Q2
Sell
-147,384
Closed -$1.76M 1078
2016
Q1
$1.76M Buy
147,384
+21,426
+17% +$225K ﹤0.01% 620
2015
Q4
$1.68M Buy
125,958
+119,458
+1,838% +$1.47M ﹤0.01% 644
2015
Q3
$69K Buy
+6,500
New +$71K ﹤0.01% 900

Other funds holding LXRX